We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Therapy for Lung and Ovarian Cancer Advances to Early-stage Clinical Development

News   Apr 27, 2020 | Orignal story from MD Anderson Cancer Ceter

 
New Therapy for Lung and Ovarian Cancer Advances to Early-stage Clinical Development
 
 
Advertisement
 

RELATED ARTICLES

FDA Grants Fast Track Designation to Onvansertib for Second-line Treatment of KRAS-mutated Colorectal Cancer

News

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

READ MORE

Solving the Medical Mystery of Anesthesia

News

Researchers have solved the longstanding mystery of the mechanisms behind the effects of anesthetics.

READ MORE

A Small Twist in Protein Structure Leads to a Big Reaction

News

Researchers devised a way to modify amide bonds with a twist to their chemical structure that significantly speeds up reactions.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE